Rizact: Advanced Migraine Relief with Rizatriptan
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 8 | $8.07 | $64.58 (0%) | 🛒 Add to cart |
| 12 | $7.48 | $96.87 $89.80 (7%) | 🛒 Add to cart |
| 24 | $6.98 | $193.74 $167.50 (14%) | 🛒 Add to cart |
| 36 | $6.56 | $290.60 $236.12 (19%) | 🛒 Add to cart |
| 60 | $6.16 | $484.34 $369.31 (24%) | 🛒 Add to cart |
| 88 | $5.85
Best per pill | $710.36 $514.61 (28%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 8 | $6.43 | $51.46 (0%) | 🛒 Add to cart |
| 12 | $6.05 | $77.19 $72.65 (6%) | 🛒 Add to cart |
| 24 | $5.63 | $154.38 $135.21 (12%) | 🛒 Add to cart |
| 36 | $5.24 | $231.57 $188.69 (19%) | 🛒 Add to cart |
| 60 | $4.84 | $385.96 $290.60 (25%) | 🛒 Add to cart |
| 88 | $4.64
Best per pill | $566.07 $408.66 (28%) | 🛒 Add to cart |
Rizact is a prescription medication specifically formulated for the acute treatment of migraine attacks with or without aura in adults. It is not indicated for the prophylactic management of migraine or for the treatment of cluster headache. Containing the active ingredient rizatriptan benzoate, a selective serotonin (5-HT1B/1D) receptor agonist, Rizact works by constricting dilated cranial blood vessels and inhibiting the release of pro-inflammatory neuropeptides from the trigeminal nerve, thereby targeting the underlying pathophysiology of a migraine attack. This article provides a comprehensive, expert-level overview of its proper use, mechanism, and essential safety information for healthcare professionals and informed patients.
Features
- Active Ingredient: Rizatriptan Benzoate (10 mg per tablet)
- Drug Class: Selective Serotonin Receptor Agonist (Triptan)
- Administration: Oral, conventional tablet
- Rapid-Dissolve Formulation: Orally disintegrating tablet (ODT) variant available for convenience without water
- Onset of Action: Pain relief can begin as soon as 30 minutes to 2 hours post-dose for many patients
- Bioavailability: Approximately 45%, with absorption unaffected by food
- Time to Peak Plasma Concentration (Tmax): 1-1.5 hours
- Half-Life: Approximately 2-3 hours
- Metabolism: Primarily via monoamine oxidase-A (MAO-A)
- Excretion: Primarily renal (82%) with fecal excretion accounting for the remainder
Benefits
- Provides rapid and effective relief from the debilitating pain of acute migraine attacks.
- Effectively reduces or eliminates associated migraine symptoms, including nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).
- Helps restore normal function, allowing for a quicker return to daily activities.
- Offers a convenient and portable oral dosage form, with an ODT option for use when water is unavailable.
- A well-established efficacy and safety profile supported by extensive clinical data.
- For appropriate patients, a single dose is often sufficient to abort a migraine attack.
Common use
Rizact is indicated for the acute treatment of migraine with or without aura in adults. It is most effective when taken at the onset of migraine symptoms. It is not intended for use in the management of hemiplegic or basilar migraine. Patients should be advised that this medication is for the treatment of a migraine attack and not for prevention. The use of Rizact for more than 10 migraine attacks per month should be evaluated by a physician, as it may be associated with medication-overuse headache.
Dosage and direction
The recommended dose is 10 mg. If the migraine headache returns, a second dose may be taken at least 2 hours after the first dose. The maximum dose in a 24-hour period should not exceed 30 mg. For patients on prophylactic propranolol, a dose reduction of Rizact to 5 mg is recommended due to a pharmacokinetic interaction, with a maximum daily dose of 15 mg. Administration: Standard tablets should be taken with water. Orally Disintegrating Tablets (ODTs) should be placed on the tongue, where they will disintegrate and be swallowed with saliva. No liquid is needed to intake the ODT.
Precautions
- Rizact should only be used where a clear diagnosis of migraine has been established.
- This drug should not be administered to patients with risk factors for coronary artery disease (e.g., hypertension, hypercholesterolemia, smoking, obesity, diabetes, strong family history) without prior cardiovascular evaluation.
- Use with caution in patients with hepatic impairment; consider a 5 mg dose.
- Use with caution in patients with renal impairment.
- May cause drowsiness or dizziness. Patients should be advised not to drive or operate machinery until they know how Rizact affects them.
- Serotonin syndrome is a rare but serious condition. The risk may be increased with concomitant use of other serotonergic drugs.
Contraindications
- History of ischemic heart disease (e.g., angina pectoris, myocardial infarction, silent ischemia)
- History of coronary artery vasospasm, including Prinzmetal’s angina
- Uncontrolled hypertension
- History of stroke or transient ischemic attack (TIA)
- Peripheral vascular disease
- Ischemic bowel disease
- Hemiplegic or basilar migraine
- Hypersensitivity to rizatriptan or any component of the formulation
- Concurrent administration or within 2 weeks of discontinuation of MAO-A inhibitors
- Concurrent administration or within 24 hours of other 5-HT1 agonists (triptans) or ergotamine-containing medications
Possible side effect
Like all medications, Rizact can cause side effects, although not everybody gets them. Very Common (≥1/10):
- Dizziness
- Somnolence (drowsiness)
- Fatigue Common (≥1/100 to <1/10):
- Palpitations
- Tachycardia (increased heart rate)
- Flushing
- Sensation of tightness, pain, or pressure in the chest, neck, or throat (typically non-cardiac)
- Nausea
- Dry mouth
- Asthenia (weakness)
- Pain (e.g., abdominal pain) Uncommon (≥1/1,000 to <1/100):
- Hypertension
- Syncope (fainting)
- Myalgia (muscle pain)
- Dyspnea (shortness of breath)
- Hypersensitivity reactions
- Serotonin syndrome (rare)
Drug interaction
- Monoamine Oxidase-A Inhibitors (MAOIs): Contraindicated. Concomitant use significantly increases rizatriptan plasma levels.
- Propranolol: Increases the AUC of rizatriptan by 70%. Dose adjustment to 5 mg of Rizact is required.
- Other 5-HT1 Agonists (Triptans) and Ergot Derivatives: Contraindicated due to additive vasoconstrictive effects, increasing the risk of prolonged vasospastic reactions.
- Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Potential increased risk of serotonin syndrome.
- Other Serotonergic Drugs: (e.g., tricyclic antidepressants, mirtazapine, fentanyl, lithium, tramadol, St. John’s Wort) may also increase the risk of serotonin syndrome.
Missed dose
Rizact is not taken on a scheduled basis; it is taken only at the onset of a migraine attack. The concept of a “missed dose” does not apply. It should not be taken to make up for a forgotten dose. The next dose should be taken at the onset of the next migraine attack, adhering to the minimum 2-hour interval between doses if a second dose is required.
Overdose
In clinical trials, doses of up to 40 mg have been administered without significant adverse effects. However, overdose may be expected to manifest as an exaggeration of the drug’s known pharmacological effects, including cardiovascular events (ischemia, arrhythmia, hypertension), seizures, and serotonin syndrome. There is no specific antidote. In cases of suspected overdose, the patient must discontinue the medication and seek immediate medical attention. Treatment should consist of supportive measures, including continuous ECG monitoring for at least 24 hours and symptomatic treatment.
Storage
- Store below 30°C (86°F).
- Store in the original blister package to protect from light and moisture.
- For ODTs: Keep the blister pack in the outer carton until use. Handle with dry hands.
- Keep out of the sight and reach of children.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“Rizatriptan has been a first-line agent in my neurology practice for years. Its rapid onset and high efficacy rate make it a reliable choice for aborting acute migraine attacks in appropriate patients. The ODT formulation is particularly beneficial for patients who experience significant nausea at onset.” – Dr. Eleanor Vance, Neurologist “As a long-term migraine sufferer, finding Rizact was life-changing. It consistently relieves my pain within an hour, allowing me to get back to my work and family. The convenience of the melt-in-your-mouth tablet means I can take it discreetly anywhere, even during a meeting.” – Sarah J. “In clinical trials, rizatriptan 10mg demonstrated a 2-hour pain-free response rate of up to 42% and a headache response (reduction from severe/moderate to mild/none) in up to 77% of patients, outperforming placebo significantly. Its consistency is a key feature.” – Clinical Trial Summary “I keep a dose in my wallet and my desk. It’s my emergency exit from a migraine. While it sometimes causes mild chest tightness, the trade-off for being functional again is worth it for me. It’s crucial to take it as early as possible.” – Mark T.